Literature DB >> 28295715

Grb7 protein RA domain oligomerization.

Malika P Godamudunage1,2, Albert Foster3, Darius Warren4, Barbara A Lyons2.   

Abstract

The growth factor receptor bound protein 7 (Grb7) is an adaptor protein that is often coamplified with the erythroblastosis oncogene B 2 receptor in 20% to 30% of breast cancer patients. Grb7 overexpression has been linked to increased cell migration and cancer metastasis. The ras associating and pleckstrin homology domain region of Grb7 has been reported to interact with various other downstream signaling proteins such as four and half Lin11, Isl-1, Mec-3 (LIM) domains isoform 2 and filamin α. These interactions are believed to play a role in regulating Grb7-mediated cell migration function. The full-length Grb7 protein has been shown to dimerize, and the oligomeric state of the Grb7SH2 domain has been extensively studied; however, the oligomerization state of the ras associating and pleckstrin homology domains, and the importance of this oligomerization in Grb7 function, is yet to be fully known. In this study, we characterize the oligomeric state of the Grb7RA domain using size exclusion chromatography, nuclear magnetic resonance, nuclear relaxation studies, glutaraldehyde cross linking, and dynamic light scattering. We report the Grb7RA domain can exist in transient multimeric forms and, based upon modeling results, postulate the potential role of Grb7RA domain oligomerization in Grb7 function.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Grb7; RAPH domains; cancer; cell migration; oligomerization

Mesh:

Substances:

Year:  2017        PMID: 28295715      PMCID: PMC6005685          DOI: 10.1002/jmr.2620

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  32 in total

Review 1.  Regulation and functional roles of Grb14.

Authors:  Bertrand Cariou; Veronique Bereziat; Karine Moncoq; Anne Kasus-Jacobi; Dominique Perdereau; Veronique Le Marcis; Anne-Francoise Burnol
Journal:  Front Biosci       Date:  2004-05-01

2.  Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene.

Authors:  Makoto Saito; Yukiko Kato; Emi Ito; Jiro Fujimoto; Kosuke Ishikawa; Ayano Doi; Kentaro Kumazawa; Atsuka Matsui; Shiori Takebe; Takaomi Ishida; Sakura Azuma; Hiromi Mochizuki; Yoshifumi Kawamura; Yuka Yanagisawa; Reiko Honma; Jun-ichi Imai; Hirokazu Ohbayashi; Naoki Goshima; Kentaro Semba; Shinya Watanabe
Journal:  FEBS Lett       Date:  2012-05-11       Impact factor: 4.124

3.  Inhibition of hGrb10 binding to the insulin receptor by functional domain-mediated oligomerization.

Authors:  L Q Dong; S Porter; D Hu; F Liu
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

4.  Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.

Authors:  Rana Mroue; Brian Huang; Steve Braunstein; Ari J Firestone; Jean L Nakamura
Journal:  PLoS Genet       Date:  2015-05-22       Impact factor: 5.917

5.  Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

Authors:  Shinji Tanaka; Stephanie C Pero; Kenichi Taguchi; Mitsuo Shimada; Masaki Mori; David N Krag; Shigeki Arii
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

6.  Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.

Authors:  Sharareh Siamakpour-Reihani; Tabitha A Peterson; Andrew M Bradford; Haroula J Argiros; Laura Lowell Haas; Siamee N Lor; Zachary M Haulsee; Anne M Spuches; Dennis L Johnson; Larry R Rohrschneider; Charles Brad Shuster; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2011 Mar-Apr       Impact factor: 2.137

7.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

8.  Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.

Authors:  De Pradip; Mark Bouzyk; Nandini Dey; Brian Leyland-Jones
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

9.  Chromosome 17 copy number changes in male breast cancer.

Authors:  Miangela M Lacle; Cathy B Moelans; Robert Kornegoor; Carmen van der Pol; Arjen J Witkamp; Elsken van der Wall; Josef Rueschoff; Horst Buerger; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2015-04-24       Impact factor: 6.730

10.  Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells.

Authors:  S C Pero; G S Shukla; M M Cookson; S Flemer; D N Krag
Journal:  Br J Cancer       Date:  2007-04-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.